CMS Strategy Weekly: Rate expectations see upward revision
Expect higher contribution from AI revenue in 3Q; Upgrade to Buy
Expect higher ASP following China’s stimulus
China Economy – Exports continued to beat expectations with uncertainty ahead
China Pharmaceutical & Healthcare - Expecting global funding recovery in the coming quarters
3Q24 net profit +38% YoY, beat expectations; US remains the most promising market
Unable to meet the expectation of dual engines
China Policy – Credit growth is expected to rebound in 2023
1H24 preview: margin weakness priced in; expect gradual ASP/margin recovery in 2H
Operation Aspides, or the Peril of Low Expectations in Yemen